7 Is the New 8: Improving Adherence to Restrictive PRBC Transfusions in the Pediatric ICU

Insights

Anemia is common in pediatric intensive care units (PICUs). Implementing an innovative awareness campaign improved adherence to restrictive packed red blood cell (pRBC) transfusion guidelines, enhancing patient care.

Area of Science:

  • Pediatric Intensive Care
  • Hematology
  • Quality Improvement

Background:

  • Anemia affects 30%-40% of pediatric intensive care unit (PICU) patients.
  • Approximately 15% of these patients receive packed red blood cell (pRBC) transfusions.
  • Current guidelines recommend a hemoglobin threshold of ≤7 g/dL for most PICU transfusions.

Purpose of the Study:

  • To evaluate pRBC transfusion rates and guideline compliance in a PICU.
  • To identify patient-level factors influencing transfusion practices.
  • To implement a novel practice strategy using cross-industry innovation.

Main Methods:

  • A pre-post study design was employed.
  • Baseline pRBC transfusion data were collected.
  • An innovation platform generated ideas for an awareness campaign and educational interventions.
  • Postintervention practices were monitored using statistical analysis (linear mixed models).

Main Results:

  • At baseline, 41% of pRBC transfusions adhered to restrictive guidelines (hemoglobin ≤7 g/dL).
  • Postintervention, adherence increased to 53% (OR 1.66, 95% CI 1.21-2.28).
  • The intervention demonstrated a statistically significant improvement in guideline compliance.

Conclusions:

  • A multi-industry innovation approach and behavioral campaign effectively improved adherence to pRBC transfusion guidelines.
  • This strategy enhanced transfusion practices in a tertiary care PICU.
  • The findings support the use of innovative interventions for optimizing transfusion protocols in critically ill children.

Related Concept Videos

Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.3K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
14.7K
Restriction Enzymes01:11

Restriction Enzymes

Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
36.0K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
532
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304